ArticleMikrochimica acta2026
Alizarin red S@ZIF-8 composite-modified carbon paste electrode: A novel sensitive sensor for the voltammetric determination of asenapine maleate in human plasma.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The development of a novel, highly sensitive electrochemical sensor for asenapine maleate (ASP) based on an alizarin red S-functionalized zeolitic imidazolate framework-8 (ALZ@ZIF-8) nanocomposite is reported. The nanocomposite was synthesized via a one-pot approach and fabricated on a carbon paste electrode (ALZ@ZIF-8/CPE). Its interaction with ASP was elucidated through density functional theory (DFT) calculations and electrochemical analysis, while its structure was confirmed using SEM, XRD, FT-IR, UV-Vis, and spectrofluorimetric techniques. Under optimized conditions, a square-wave voltammetric (SWV) method was developed and rigorously validated. The sensor demonstrated a wide linear range from 0.01 to 14.0 µM, with exceptional sub-micromolar sensitivity (detection limit: 3.45 nM; quantification limit: 10.46 nM). The method showed high accuracy (recoveries: 99.26–101.62%) and precision (relative standard deviation, RSD ≤ 1.01%). Successful application to spiked human plasma yielded recoveries ≥ 98.84% with RSDs ≤ 1.61%, confirming practical utility. This work presents the first application of the ALZ@ZIF-8 nanocomposite in analysis. The proposed sensor offers a promising and adaptable platform for the sensitive detection of ASP and other target molecules in complex biological media.
Indexed as
Identifiers
41733694What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.